(0.00%) 5 206.75 points
(0.05%) 39 017 points
(-0.07%) 18 182 points
(0.13%) $78.58
(-1.23%) $2.17
(-0.12%) $2 328.50
(-0.54%) $27.47
(0.31%) $967.90
(0.10%) $0.929
(0.23%) $10.85
(0.15%) $0.797
(-0.24%) $91.13
2 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 13.69%
12.87% $ 1.140
Live Chart Being Loaded With Signals
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States...
Stats | |
---|---|
Volumen de hoy | 2.75M |
Volumen promedio | 1.11M |
Capitalización de mercado | 128.42M |
EPS | $0 ( 2024-03-07 ) |
Próxima fecha de ganancias | ( $-0.100 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.56 |
ATR14 | $0.00700 (0.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-18 | Krick Anthony J | Sell | 2 345 | Common Stock |
2024-03-15 | Marino Michael F Iii | Buy | 3 816 | Common Stock |
2024-03-18 | Marino Michael F Iii | Sell | 15 059 | Common Stock |
2024-03-15 | Mahmoud Ramy A | Buy | 6 114 | Common Stock |
2024-03-18 | Mahmoud Ramy A | Sell | 19 198 | Common Stock |
INSIDER POWER |
---|
-24.20 |
Last 98 transactions |
Buy: 6 923 187 | Sell: 11 541 596 |
Volumen Correlación
OptiNose Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
FONR | 0.899 |
EQIX | 0.894 |
ULTA | 0.872 |
GRPN | 0.871 |
NUVL | 0.868 |
CRSP | 0.858 |
IPW | 0.847 |
BIMI | 0.846 |
KNSA | 0.846 |
CTRN | 0.84 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OptiNose Inc Correlación - Moneda/Commodity
OptiNose Inc Finanzas
Annual | 2023 |
Ingresos: | $70.99M |
Beneficio Bruto: | $61.95M (87.27 %) |
EPS: | $-0.320 |
FY | 2023 |
Ingresos: | $70.99M |
Beneficio Bruto: | $61.95M (87.27 %) |
EPS: | $-0.320 |
FY | 2022 |
Ingresos: | $76.28M |
Beneficio Bruto: | $67.01M (87.86 %) |
EPS: | $-0.890 |
FY | 2021 |
Ingresos: | $74.65M |
Beneficio Bruto: | $65.50M (87.74 %) |
EPS: | $-1.450 |
Financial Reports:
No articles found.
OptiNose Inc
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico